| SC 13G | 2005-02-14 | BARCLAYS GLOBAL INVESTORS NA /CA/ | HAEMONETICS CORP | 2,554,475 | 10.0% | EDGAR |
| SC 13G/A | 2005-02-10 | VANGUARD SPECIALIZED FUNDS | HAEMONETICS CORP | 1,755,400 | 6.9% | EDGAR |
| SC 13G/A | 2005-02-07 | COOKE & BIELER LP | HAEMONETICS CORP | 1,571,340 | 6.2% | EDGAR |
| SC 13G/A | 2005-01-06 | STERLING CAPITAL MANAGEMENT LLC | HAEMONETICS CORP | 29,615 | 0.1% | EDGAR |
| SC 13G | 2004-09-14 | BARCLAYS GLOBAL INVESTORS NA /CA/ | HAEMONETICS CORP | 2,013,772 | 8.0% | EDGAR |
| SC 13G/A | 2004-02-13 | NEUBERGER BERMAN INC | HAEMONETICS CORP | 2,877,267 | 11.9% | EDGAR |
| SC 13G/A | 2004-02-12 | WELLINGTON MANAGEMENT CO LLP | HAEMONETICS CORP | 2,632,150 | 10.9% | EDGAR |
| SC 13G | 2004-02-11 | COOKE & BIELER LP | HAEMONETICS CORP | 1,884,651 | 7.8% | EDGAR |
| SC 13D/A | 2004-02-06 | BLUM CAPITAL PARTNERS LP | HAEMONETICS CORP | 1,166,800 | 4.8% | EDGAR |
| SC 13G/A | 2004-02-05 | VANGUARD SPECIALIZED FUNDS | HAEMONETICS CORP | 1,983,900 | 8.2% | EDGAR |
| SC 13G/A | 2004-01-09 | STERLING CAPITAL MANAGEMENT LLC | HAEMONETICS CORP | 1,725,116 | 7.1% | EDGAR |
| SC 13D/A | 2003-08-20 | BLUM CAPITAL PARTNERS LP | HAEMONETICS CORP | 1,425,600 | 5.9% | EDGAR |
| SC 13D/A | 2003-08-08 | BLUM CAPITAL PARTNERS LP | HAEMONETICS CORP | 1,444,200 | 6.0% | EDGAR |
| SC 13D/A | 2003-06-24 | BLUM CAPITAL PARTNERS LP | HAEMONETICS CORP | 1,773,900 | 7.3% | EDGAR |
| SC 13D/A | 2003-06-19 | BLUM CAPITAL PARTNERS LP | HAEMONETICS CORP | 2,110,400 | 8.7% | EDGAR |
| SC 13D/A | 2003-06-03 | BLUM CAPITAL PARTNERS LP | HAEMONETICS CORP | 2,470,600 | 10.2% | EDGAR |
| SC 13G/A | 2003-06-03 | PETERSON JAMES L | HAEMONETICS CORP | 1,261,532 | 4.9% | EDGAR |
| SC 13G/A | 2003-06-03 | PETERSON JAMES L | HAEMONETICS CORP | 1,364,293 | 5.4% | EDGAR |
| SC 13G | 2003-06-03 | PETERSON JAMES L | HAEMONETICS CORP | 1,348,388 | 5.2% | EDGAR |
| SC 13G | 2003-06-03 | PETERSON JAMES L | HAEMONETICS CORP | 1,416,927 | 5.2% | EDGAR |